The table below shows Olema Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$45.99M
-$43.98M
-$23.50M
-$20.39M
-$17.90M
-$11.08M
Capital expenditure
-
-
$153.00K
-
$30.00K
$420.00K
Investing cash flow
$4.53M
-$45.08M
-$20.14M
$37.39M
$25.57M
-$279.58M
Dividends paid
-
-
-
-
OLMA operating cash flow (10-K history)
Olema Pharmaceuticals, Inc. reported operating cash flow of -$146.72M for fiscal year 2025. That is down 40.6% from -$104.35M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$3.08M (FY 2019) to -$146.72M. Figures come from the company's audited annual reports as filed with the SEC.